AIG
APLS

American International Group’s Apellis Pharmaceuticals APLS Stock Holding History

American International Group’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,685
Closed -$99K – 184
2024
Q1 		$99K Sell
1,685
-25
-1% -$1.59K ﹤0.01% 2519
2023
Q4 		$102K Sell
1,710
-23
-1% -$1.17K ﹤0.01% 2554
2023
Q3 		$65.9K Sell
1,733
-121
-7% -$5.32K ﹤0.01% 2736
2023
Q2 		$169K Sell
1,854
-43,407
-96% -$3.75M ﹤0.01% 2273
2023
Q1 		$2.99M Buy
45,261
+900
+2% +$51.9K 0.02% 865
2022
Q4 		$2.29M Sell
44,361
-161
-0.4% -$8.54K 0.02% 914
2022
Q3 		$3.04M Buy
44,522
+1,964
+5% +$116K 0.02% 839
2022
Q2 		$1.92M Buy
42,558
+3,742
+10% +$171K 0.01% 956
2022
Q1 		$1.97M Buy
38,816
+828
+2% +$36.6K 0.01% 1025
2021
Q4 		$1.8M Buy
37,988
+2,439
+7% +$96K 0.01% 1125
2021
Q3 		$1.17M Sell
35,549
-845
-2% -$47.5K 0.01% 1352
2021
Q2 		$2.3K Buy
36,394
+1,393
+4% +$71.9K 0.01% 1057
2021
Q1 		$1.5K Buy
35,001
+92
+0.3% +$4.35K 0.01% 1264
2020
Q4 		$2K Sell
34,909
-1,002
-3% -$42.4K 0.01% 1078
2020
Q3 		$1.08M Sell
35,911
-816
-2% -$24.4K 0.01% 1208
2020
Q2 		$1.2M Buy
36,727
+2,850
+8% +$91.5K 0.01% 1134
2020
Q1 		$908K Buy
33,877
+3,297
+11% +$117K 0.01% 1153
2019
Q4 		$936K Buy
30,580
+59
+0.2% +$1.63K ﹤0.01% 1369
2019
Q3 		$735K Sell
30,521
-213
-0.7% -$5.86K ﹤0.01% 1463
2019
Q2 		$779K Buy
30,734
+7,704
+33% +$157K ﹤0.01% 1459
2019
Q1 		$449K Sell
23,030
-747
-3% -$11.7K ﹤0.01% 1773
2018
Q4 		$314K Sell
23,777
-183
-0.8% -$2.81K ﹤0.01% 1920
2018
Q3 		$426K Buy
23,960
+432
+2% +$7.99K ﹤0.01% 1987
2018
Q2 		$518K Buy
23,528
+16,457
+233% +$378K ﹤0.01% 1813
2018
Q1 		$156K Sell
7,071
-221
-3% -$4.34K ﹤0.01% 2401
2017
Q4 		$158K Buy
+7,292
New +$107K ﹤0.01% 2461

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American International Group's APLS Position: Q2 2024 in Review

American International Group sold out of Apellis Pharmaceuticals (APLS) in Q2 2024, closing a stake of 1,685 shares — an estimated $99K sold.

American International Group first reported a position in APLS in Q4 2017 and held it in 26 quarters. The position peaked at $3.04M in Q3 2022. 263 funds tracked by Wall St. Rank hold APLS as of Q2 2024.

  • American International Group reported no remaining Apellis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,685 Apellis Pharmaceuticals shares in Q2 2024, an estimated $99K.
  • American International Group first reported a position in Apellis Pharmaceuticals in Q4 2017 and held it in 26 quarters.
  • American International Group's Apellis Pharmaceuticals position peaked at $3.04M in Q3 2022.
  • 263 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.